These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17516871)

  • 1. Botulinum neurotoxin type A in facial aesthetics.
    De Boulle KL
    Expert Opin Pharmacother; 2007 Jun; 8(8):1059-72. PubMed ID: 17516871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products.
    Dessy LA; Fallico N; Mazzocchi M; Scuderi N
    Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid filler and botulinum Neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy.
    Kenner JR
    J Drugs Dermatol; 2010 Sep; 9(9):1135-8. PubMed ID: 20865847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What does the future hold for botulinum neuromodulators in facial aesthetics?
    Sattler G
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):394-5. PubMed ID: 21492251
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin injection for facial wrinkles.
    Small R
    Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin in facial rejuvenation: an update.
    Carruthers J; Carruthers A
    Dermatol Clin; 2009 Oct; 27(4):417-25, v. PubMed ID: 19850191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diplopia following subcutaneous injections of botulinum toxin for cosmetic or medical use].
    Sheen-Ophir S; Almog Y
    Harefuah; 2013 Feb; 152(2):98-100, 123, 122. PubMed ID: 23513501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation.
    Aristodemou P; Watt L; Baldwin C; Hugkulstone C
    Ophthalmic Plast Reconstr Surg; 2006; 22(2):134-6. PubMed ID: 16550061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion characteristics of botulinum neurotoxin products and their clinical significance in cosmetic applications.
    de Almeida AT; De Boulle K
    J Cosmet Laser Ther; 2007; 9 Suppl 1():17-22. PubMed ID: 17885882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin products overview.
    Carruthers A; Carruthers J
    Skin Therapy Lett; 2008; 13(6):1-4. PubMed ID: 18806905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of botulinum neurotoxins.
    Lowe NJ
    J Cosmet Laser Ther; 2007; 9 Suppl 1():11-6. PubMed ID: 17885881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The evolution of botulinum neurotoxin type A for cosmetic applications.
    Carruthers J; Carruthers A
    J Cosmet Laser Ther; 2007 Sep; 9(3):186-92. PubMed ID: 17763029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating glabellar lines with botulinum toxin type A-hemagglutinin complex: a review of the science, the clinical data, and patient satisfaction.
    De Boulle K; Fagien S; Sommer B; Glogau R
    Clin Interv Aging; 2010 Apr; 5():101-18. PubMed ID: 20458348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total dental aesthetics.
    Maklcmacher L
    Dent Today; 2013 Nov; 32(11):134, 136-7. PubMed ID: 24358552
    [No Abstract]   [Full Text] [Related]  

  • 15. Botulinum neurotoxin A: a review.
    Berry MG; Stanek JJ
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1283-91. PubMed ID: 22552262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining fillers and neuromodulators in the same syringe.
    Kenner J
    J Drugs Dermatol; 2014 Feb; 13(2):110. PubMed ID: 24509957
    [No Abstract]   [Full Text] [Related]  

  • 17. Combining fillers and neuromodulators in the same syringe.
    Cohen JL; Mariwall K
    J Drugs Dermatol; 2013 Sep; 12(9):976. PubMed ID: 24002142
    [No Abstract]   [Full Text] [Related]  

  • 18. Incorporating facial rejuvenation procedures in the dental practice.
    Roberts W
    Todays FDA; 2013; 25(2):50-3. PubMed ID: 23691617
    [No Abstract]   [Full Text] [Related]  

  • 19. Botulinum toxin type A: history and current cosmetic use in the upper face.
    Carruthers A
    Dis Mon; 2002 May; 48(5):299-322. PubMed ID: 12195262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABOUT FACE: Navigating Neuromodulators and Injection Techniques for Optimal Results.
    Yoelin SG; Aguilera SB; Cohen JL; Gold MH; Kaufman J; Maas CS
    J Drugs Dermatol; 2020 Apr; 19(4):s5-s15. PubMed ID: 32243119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.